Sponsored by: GE Healthcare

Molecular Imaging: Page 107

PET IDs lung cancer patients for personalized therapy
By AuntMinnieEurope.com staff writers
A noninvasive PET imaging technique may identify lung cancers that respond best to tyrosine kinase inhibitors, according to research presented at the 14th World Conference on Lung Cancer being held in Amsterdam this week.
July 5, 2011
FDG-PET/CT useful in detecting malignancy of ovarian tumors
By Wayne Forrest
Danish researchers have found that FDG-PET/CT can provide beneficial information on the possible malignancy of ovarian tumors and help gynecologists determine the correct course of treatment for patients.
July 5, 2011
France invests in nuclear medicine
By AuntMinnieEurope.com staff writers
French President Nicolas Sarkozy has confirmed plans to invest 1 billion euros in future nuclear programs, including a fourth-generation reactor research, according to a report in World Nuclear News.
June 29, 2011
Lantheus launches phase III flurpiridaz F-18 trial
By AuntMinnieEurope.com staff writers
Lantheus Medical Imaging has launched the first of two phase III clinical trials of a PET radiopharmaceutical for use in detecting coronary artery disease.
June 29, 2011
Aspect Imaging partners with Cage
By AuntMinnieEurope.com staff writers
Aspect Imaging has signed an agreement with Cage Chemicals to develop and manufacture Aspect's PhenoQuant line of contrast agents for preclinical research.
June 28, 2011
PET/MRI at 9.4T promises gains in neuroimaging
By Eric Barnes
BERLIN - The marriage of PET and ultrahigh-field MRI offers a world of intriguing possibilities in neuroimaging -- including tools to analyze complex neural mechanisms and improve physicians' understanding of neurological disease processes, according to a presentation at the Scientific Symposium on Ultrahigh Field Magnetic Resonance.
June 23, 2011
2011 06 24 15 59 07 371 2011 06 24 High Field Thumb
Philips inks nuclear medicine deal with Russia
By AuntMinnieEurope.com staff writers
Philips Healthcare parent Royal Philips Electronics and Rosatom, the Russian State Atomic Energy Corporation, have signed a nuclear medicine research and manufacturing deal.
June 19, 2011
IBA, Wilex meet FDA on Redectane trial
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) and drug company Wilex recently met with the U.S. Food and Drug Administration to discuss the regulatory review process for IBA's Redectane PET/CT radiopharmaceutical.
June 19, 2011
Don't write off nuclear cardiology, urges U.K. specialist
By Edna Astbury-Ward, PhD
The stunning success of cardiac CT perfusion has led some experts to question whether nuclear cardiology has a future, but it may be premature to write off nuclear cardiology. It is a robust, tried, and tested field supported by very established data, according to a U.K. specialist.
June 7, 2011
2011 06 08 08 40 52 250 2011 06 08 Nuclear Thumb
SNM: Hybrid PET/MRI study among top 5 research papers
By Wayne Forrest
SAN ANTONIO - The first-ever study on the clinical use of PET/MRI and a breakthrough on the use of FDG-PET to detect fevers of unknown origin were among the top research papers outlined Monday at this week's Society of Nuclear Medicine (SNM) annual meeting.
June 7, 2011
2011 06 07 09 54 33 43 Fever Unknown Origin Thumb
GE signs PET agent R&D deal with ImaginAb
By AuntMinnieEurope.com staff writers
GE Healthcare has signed an R&D deal with ImaginAb to develop new PET radiopharmaceuticals based on ImaginAb's antibody fragment technology.
June 6, 2011
Siemens gets CE Mark for PET/MRI scanner
By AuntMinnieEurope.com staff writers
Siemens Healthcare has received the CE Mark for its Biograph mMR hybrid PET/MRI scanner.
May 31, 2011
Previous Page
Page 107 of 122
Next Page